These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 10406627

  • 1. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
    Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM.
    Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627
    [Abstract] [Full Text] [Related]

  • 2. Threshold power levels for NPe6 photodynamic therapy.
    Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi D, Moshfeghi AA.
    Ophthalmic Surg Lasers; 2000 Jul; 31(2):136-42. PubMed ID: 10743925
    [Abstract] [Full Text] [Related]

  • 3. Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.
    Peyman GA, Kazi AA, Moshfeghi D, Unal M, Khoobehi B, Yoneya S, Mori K, Rivera I.
    Ophthalmic Surg Lasers; 2000 Jul; 31(4):323-7. PubMed ID: 10928670
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the new photosensitizer Tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits.
    Framme C, Sachs HG, Flucke B, Theisen-Kunde D, Birngruber R.
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5437-46. PubMed ID: 17122134
    [Abstract] [Full Text] [Related]

  • 5. Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2).
    Peyman GA, Moshfeghi DM, Moshfeghi A, Khoobehi B, Doiron DR, Primbs GB, Crean DH.
    Ophthalmic Surg Lasers; 1997 May; 28(5):409-17. PubMed ID: 9150524
    [Abstract] [Full Text] [Related]

  • 6. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
    Mori K, Yoneya S, Anzail K, Kabasawa S, Sodeyama T, Peyman GA, Moshfeghi DM.
    Retina; 2001 May; 21(5):499-508. PubMed ID: 11642380
    [Abstract] [Full Text] [Related]

  • 7. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.
    Obana A, Gohto Y, Kaneda K, Nakajima S, Miki T.
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2639-45. PubMed ID: 11581211
    [Abstract] [Full Text] [Related]

  • 8. Problems with and pitfalls of photodynamic therapy.
    Peyman GA, Kazi AA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi DM.
    Ophthalmology; 2000 Jan; 107(1):29-35. PubMed ID: 10647715
    [Abstract] [Full Text] [Related]

  • 9. Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies.
    Moshfeghi DM, Peyman GA, Moshfeghi AA, Khoobehi B, Primbs GB, Crean DH.
    Ophthalmic Surg Lasers; 1998 Aug; 29(8):663-8. PubMed ID: 9715492
    [Abstract] [Full Text] [Related]

  • 10. Photothrombosis of retinal and choroidal vessels in rabbit eyes using chloroaluminum sulfonated phthalocyanine and a diode laser.
    Iliaki OE, Naoumidi II, Tsilimbaris MK, Pallikaris IG.
    Lasers Surg Med; 1996 Aug; 19(3):311-23. PubMed ID: 8923426
    [Abstract] [Full Text] [Related]

  • 11. Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.
    Nakashizuka T, Mori K, Hayashi N, Anzail K, Kanail K, Yoneya S, Moshfeghi DM, Peyman GA.
    Retina; 2001 Aug; 21(5):493-8. PubMed ID: 11642379
    [Abstract] [Full Text] [Related]

  • 12. Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys.
    Moshfeghi D, Peyman GA, Kazi AA, Unal M, Khoobehi B, Yoneya S, Mori K.
    Ophthalmic Surg Lasers; 1999 Aug; 30(9):750-3. PubMed ID: 10574497
    [Abstract] [Full Text] [Related]

  • 13. Toxicity of the photosensitizer NPe6 following intravitreal injection.
    El-Dessouky ES, Moshfeghi AA, Peyman GA, Yoneya S, Mori K, Kazi AA, Moshfeghi DM.
    Ophthalmic Surg Lasers; 2001 Aug; 32(4):316-21. PubMed ID: 11475398
    [Abstract] [Full Text] [Related]

  • 14. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].
    Mori K, Ohta M, Sano A, Yoneya S, Sonoda M, Kaneda A, Sato Y.
    Nippon Ganka Gakkai Zasshi; 1997 Feb; 101(2):134-40. PubMed ID: 9124093
    [Abstract] [Full Text] [Related]

  • 15. Retinal and choroidal vessel closure using phthalocyanine photodynamic therapy.
    Kliman GH, Puliafito CA, Grossman GA, Gregory WA.
    Lasers Surg Med; 1994 Feb; 15(1):11-8. PubMed ID: 7997044
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of photodynamic occlusion using liposomal Zn(II)-phtalocyanine.
    Schmidt-Erfurth U, Michels S, Indorf L, Eggers R, Birngruber R.
    Curr Eye Res; 2005 Jul; 30(7):601-12. PubMed ID: 16020295
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
    Berdugo M, Bejjani RA, Valamanesh F, Savoldelli M, Jeanny JC, Blanc D, Ficheux H, Scherz A, Salomon Y, BenEzra D, Behar-Cohen F.
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085
    [Abstract] [Full Text] [Related]

  • 18. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
    Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES, Miller JW.
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
    [Abstract] [Full Text] [Related]

  • 19. Experimental photodynamic effects of hypocrellin A on the choriocapillaris.
    Khoobehi B, Grinstead R, Passos E.
    Ophthalmic Surg Lasers; 2002 Sep; 33(3):207-13. PubMed ID: 12027100
    [Abstract] [Full Text] [Related]

  • 20. Feasibility of laser-targeted photoocclusion of the choriocapillary layer in rats.
    Asrani S, Zou S, D'Anna S, Lutty G, Vinores SA, Goldberg MF, Zeimer R.
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2702-10. PubMed ID: 9418722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.